keyword
https://read.qxmd.com/read/38567236/huntington-s-disease-a-report-of-an-interesting-case-and-literature-review
#1
Praveen K Sharma, Arun Aram, Yashaswinii Polaka, Vinoth Pandian
Huntington's disease (HD), referred to as Huntington's chorea, is an infrequent neurodegenerative ailment with an autosomal-dominant inheritance pattern characterized by the progressive deterioration of GABAergic neurons in the basal ganglia. Other ones include subcortical-type dementia, behavioral abnormalities, midlife psychosis, and gradual inadvertent choreoathetosis movements. HD is characterized by atrophy of the dorsal striatum (caudate nucleus and putamen) with concurrent expansion of the frontal horns of the lateral ventricles on imaging modalities such as computed tomography (CT) and magnetic resonance imaging (MRI)...
March 2024: Curēus
https://read.qxmd.com/read/38333894/case-report-a-case-of-anti-recoverin-antibody-positive-encephalitis-exhibiting-cotard-and-capgras-delusions-that-was-successfully-treated-with-electroconvulsive-therapy
#2
Takaki Akahane, Naomi Takahashi, Ryota Kobayashi, Konoka Nomura, Masakazu Akiho, Yukihiro Shikama, Keisuke Noto, Akihito Suzuki
Recoverin is a neuron-specific calcium-binding protein that is mainly located in the retina and pineal gland. Few reports have described patients with anti-recoverin antibody-positive encephalitis, and no cases of psychosis associated with this encephalitis have been reported. We report a patient with anti-recoverin antibody-positive encephalitis with Cotard and Capgras delusions who was successfully treated with electroconvulsive therapy (ECT). The patient was a 25-year-old woman. She exhibited disorientation, executive function deficits, tremors in the upper limbs, generalized athetoid-like involuntary movements, hallucinations, incontinence, and fever, which led to her admission to our hospital...
2024: Frontiers in Psychiatry
https://read.qxmd.com/read/38016060/case-report-10%C3%A2-years-follow-up-of-psychosis-due-to-fahr-s-disease-complicated-by-a-left-temporal-stroke
#3
M De Pieri, G Poglia, J Bartolomei
Fahr's disease (FD) is a rare disorder, characterized by basal ganglia calcification and presenting with movement disorders, speech impairment, cognitive deficits, and neuropsychiatric symptoms. Psychotic disorders related to FD are barely described in the literature, and knowledge is missing concerning pathophysiology, course, and management. Here, we report on the long-term follow-up of a patient who had three acute episodes of FD-psychosis characterized by bizarre delusions and behavioral disorganization, without hallucinations...
2023: Frontiers in Psychiatry
https://read.qxmd.com/read/37583127/wilson-disease-a-case-report-of-psychosis-preceding-parkinsonism
#4
JOURNAL ARTICLE
Sophie Dunkerton, Antonia J Clarke, Elizabeth O Thompson, Peter Xie, Stephen Tisch, John M Worthington, Azadeh Azadi, Gabor M Halmagyi
BACKGROUND A first psychotic episode requires the exclusion of toxic-metabolic, inflammatory, infective, and neoplastic causes. Wilson disease is a rare, autosomal recessive disorder of copper metabolism and can present with neuropsychiatric symptoms secondary to copper accumulation in the brain. CASE REPORT We describe the case of a 48-year-old man with parkinsonism on a background of longstanding schizophrenia and psychotic depression in the setting of previously undiagnosed Wilson disease. The common history of neuropsychiatric disturbance and neuroleptic use complicated the assessment of parkinsonism...
August 16, 2023: American Journal of Case Reports
https://read.qxmd.com/read/37362501/advanced-early-onset-fahr-s-disease-a-case-report
#5
Kristopher Aghemo, Ryan Salmanzadeh, Osmany DeAngelo, Austin M Salmanzadeh
Fahr's disease is a rare disorder characterized by abnormal calcium deposition within the basal ganglia, cerebellar dentate nuclei, and white matter tracts with subsequent atrophy. Typical CT imaging features include extensive symmetric calcification involving the basal ganglia and subcortical white matter. Primary Fahr's disease (also known as primary familial brain calcification) is diagnosed based on the exclusion of secondary causes such as underlying metabolic or endocrine disorders. The disease may or may not feature a detectable genetic component, which is inherited in an autosomal dominant or recessive pattern...
May 2023: Curēus
https://read.qxmd.com/read/37141483/withdrawal-emergent-dyskinesia-related-to-benztropine-a-case-report
#6
Sharadhi Thalner, Himanshu Agrawal
INTRODUCTION: Benztropine is an anticholinergic drug used as a therapy for Parkinson's disease and treatment for extrapyramidal side effects. While tardive dyskinesia is an involuntary movement disorder that often occurs gradually after long-term use of medications, it does not commonly present acutely. CASE PRESENTATION: A 31-year-old White woman experiencing psychosis presented with spontaneous, acute-onset dyskinesia induced with the withdrawal of benztropine...
May 2023: WMJ: Official Publication of the State Medical Society of Wisconsin
https://read.qxmd.com/read/37121090/cortical-and-subcortical-brain-morphometry-abnormalities-in-youth-at-clinical-high-risk-for-psychosis-and-individuals-with-early-illness-schizophrenia
#7
JOURNAL ARTICLE
Jessica P Y Hua, Rachel L Loewy, Barbara Stuart, Susanna L Fryer, Tara A Niendam, Cameron S Carter, Sophia Vinogradov, Daniel H Mathalon
Neuroimaging studies have documented morphometric brain abnormalities in schizophrenia, but less is known about them in individuals at clinical high-risk for psychosis (CHR-P), including how they compare with those observed in early schizophrenia (ESZ). Accordingly, we implemented multivariate profile analysis of regional morphometric profiles in CHR-P (n = 89), ESZ (n = 93) and healthy controls (HC; n = 122). ESZ profiles differed from HC and CHR-P profiles, including 1) cortical thickness: significant level reduction and regional non-parallelism reflecting widespread thinning, except for entorhinal and pericalcarine cortex, 2) basal ganglia volume: significant level increase and regional non-parallelism reflecting larger caudate and pallidum, and 3) ventricular volume: significant level increase with parallel regional profiles...
April 25, 2023: Psychiatry Research. Neuroimaging
https://read.qxmd.com/read/37102265/very-late-onset-schizophrenia-like-psychosis-a-case-report-and-critical-literature-review
#8
Joana Regala, Francisco Moniz-Pereira
Late-life psychosis presents a challenge, wherein a wide range of differential diagnoses should be considered. Very late-onset schizophrenia-like psychosis (VLOSLP) is a nosological entity that remains a conundrum. We provide a comprehensive literature review on the neurobiological underpinnings of VLOSLP. We describe a case that typifies the clinical presentation of VLOSLP. Although not pathognomonic, certain features, namely the two-stage progression of psychotic episode, partition delusions, multimodal hallucinations, and absent formal thought disorder or negative symptoms, are quite suggestive of VLOSLP...
June 2023: Annals of geriatric medicine and research
https://read.qxmd.com/read/36924179/neurological-soft-signs-and-schizophrenia
#9
REVIEW
Eva-Maria Tsapakis, Calypso A Mitkani, Konstantinos N Fountoulakis
Neurological soft signs (NSS) are likely to represent abnormal neurodevelopment and aberration in neural maturation and connectivity. They may not be unique to schizophrenia, but they appear to be a trait characteristic in psychosis and therefore could serve as an objective measure for the assessment of serious psychiatric disorder in the prodromal phase, at onset, and along the course of the disease. Evidence so far proposes that NSS are independent of antipsychotic treatment and therefore constitute a trait symptom, independent of the illness stage and medication...
March 16, 2023: CNS Spectrums
https://read.qxmd.com/read/36422679/rhythmic-auditory-stimulation-incorporated-in-training-improved-movements-in-individuals-with-psychotic-like-experiences
#10
JOURNAL ARTICLE
Shu-Mei Wang, Sin-Tung Chan, Yuk-Lin Wong, Hsiao-Man Hsu, Cheuk-Yan Lee, Chung-Yin Check, Cheuk-Kiu Leung
Movement abnormalities, including movement slowing and irregular muscle contraction, exist in individuals with psychotic-like experiences (PLEs) and serve as vulnerable factors of developing psychotic diseases in the psychosis continuum. To date scarce studies have developed early intervention programs tackling these initial impairments, which may be caused by basal ganglia alterations, in the early stage of the psychosis course. Rhythmic auditory stimulation (RAS) is a technique of neurological music therapy and has been proved effective in inducing faster movements in patients with psychotic diseases...
November 24, 2022: European Archives of Psychiatry and Clinical Neuroscience
https://read.qxmd.com/read/36096294/intact-amphetamine-induced-behavioral-sensitization-in-mice-with-increased-or-decreased-neuronal-glutamate-transporter-slc1a1-eaat3
#11
JOURNAL ARTICLE
Muhammad O Chohan, Hannah Yueh, Halli Fein, Jared M Kopelman, Susanne E Ahmari, Jeremy Veenstra-VanderWeele
Repeated amphetamine treatment results in locomotor sensitization, a phenomenon that may relate to the development of psychosis and addiction. Evidence suggests that interactions between dopaminergic and glutamatergic systems are involved in amphetamine sensitization. We previously demonstrated that the neuronal excitatory amino acid transporter (Slc1a1/EAAT3) produces bidirectional, expression-dependent effects on the response to acute amphetamine. Here, using mice with decreased or increased expression of EAAT3, we found that chronic alterations in EAAT3 expression do not significantly impact amphetamine-induced locomotor sensitization...
September 9, 2022: Neurochemistry International
https://read.qxmd.com/read/35915336/impairments-in-goal-directed-action-and-reversal-learning-in-a-proportion-of-individuals-with-psychosis
#12
JOURNAL ARTICLE
Shuichi Suetani, Andrea Baker, Kelly Garner, Peter Cosgrove, Matilda Mackay-Sim, Dan Siskind, Graham K Murray, James G Scott, James P Kesby
Cognitive impairment in psychosis is one of the strongest predictors of functional decline. Problems with decision-making processes, such as goal-directed action and reversal learning, can reflect cortico-striatal dysfunction. The heterogenous symptoms and neurobiology observed in those with psychosis suggests that specific cognitive phenotypes may reflect differing causative mechanisms. As such, decision-making performance could identify subgroups of individuals with more severe cortico-striatal dysfunction and help to predict their functional decline...
August 2, 2022: Cognitive, Affective & Behavioral Neuroscience
https://read.qxmd.com/read/35853869/the-neural-substrates-of-neurological-soft-signs-in-schizophrenia-a-systematic-review
#13
REVIEW
Genelle D Samson, Adrienne C Lahti, Nina V Kraguljac
Neurological soft signs (NSS) are common in patients with schizophrenia. However, the neural substrates of NSS remain poorly understood. Using legacy PubMed, we performed a systematic review and included studies that assessed NSS and obtained neuroimaging data in patients with a schizophrenia spectrum disorder published up to June 2020. We systematically reviewed 35 relevant articles. Studies consistently implicate the basal ganglia and cerebellum as structural substrates of NSS and suggest that somatomotor and somatosensory regions as well as areas involved in visual processing and spatial orientation may underlie NSS in psychosis spectrum disorders...
April 26, 2022: Schizophrenia (Heidelb)
https://read.qxmd.com/read/35730515/letter-to-the-editor-depression-as-the-first-symptom-of-frontal-lobe-grade-2-malignant-glioma
#14
LETTER
Şerif Bora Nazlı, Muhammet Sevindik
Dear Editor, Next to focal neurological symptoms, epileptic seizures and head aches, brain tumors can less frequently bring about cognitive changes, slowed speech, difficulty sustaining mental functioning and psychiatric symptoms of personality changes and. loss of interest in daily activities, these symptoms may be evaluated as anxiety or depression. Depression is known to be a complication of brain tumours and may sometimes be seen after the presentation of neurological symptoms linked to brain tumours, and sometimes after tumor treatment (Oğuz et al...
2022: Türk Psikiyatri Dergisi, Turkish Journal of Psychiatry
https://read.qxmd.com/read/35730361/brain-glucose-metabolism-in-schizophrenia-a-systematic-review-and-meta-analysis-of-18-fdg-pet-studies-in-schizophrenia
#15
JOURNAL ARTICLE
Leigh Townsend, Toby Pillinger, Pierluigi Selvaggi, Mattia Veronese, Federico Turkheimer, Oliver Howes
BACKGROUND: Impaired brain metabolism may be central to schizophrenia pathophysiology, but the magnitude and consistency of metabolic dysfunction is unknown. METHODS: We searched MEDLINE, PsychINFO and EMBASE between 01/01/1980 and 13/05/2021 for studies comparing regional brain glucose metabolism using 18 FDG-PET, in schizophrenia/first-episode psychosis v. controls. Effect sizes (Hedges g ) were pooled using a random-effects model. Primary measures were regional absolute and relative CMRGlu in frontal, temporal, parietal and occipital lobes, basal ganglia and thalamus...
June 22, 2022: Psychological Medicine
https://read.qxmd.com/read/35628144/early-life-stress-alters-expression-of-glucocorticoid-stress-response-genes-and-trophic-factor-transcripts-in-the-rodent-basal-ganglia
#16
JOURNAL ARTICLE
Cynthia Haidee Tran, Cynthia Shannon Weickert, Thomas Wesley Weickert, Duncan Sinclair
Early life stress shapes the developing brain and increases risk for psychotic disorders. Yet, it is not fully understood how early life stress impacts brain regions in dopaminergic pathways whose dysfunction can contribute to psychosis. Therefore, we investigated gene expression following early life stress in adult brain regions containing dopamine neuron cell bodies (substantia nigra, ventral tegmental area (VTA)) and terminals (dorsal/ventral striatum). Sprague-Dawley rats (14F, 10M) were separated from their mothers from postnatal days (PND) 2-14 for 3 h/day to induce stress, while control rats (12F, 10M) were separated for 15 min/day over the same period...
May 10, 2022: International Journal of Molecular Sciences
https://read.qxmd.com/read/35515509/bilateral-striopallidal-calcinosis-secondary-to-systemic-lupus-erythematosus
#17
Juan Felipe Betancur, José A Goméz-Puerta, Juan Felipe Llano, Gustavo Adolfo Lopéz-Ochoa, Beatriz Ramirez, Oscar David Martinez
Bilateral symmetric striatopallidal calcinosis with or without deposits in dentate nucleus, thalamus, and white matter is reported in patients ranging from asymptomatic, metabolic, toxic, and genetic autosomal dominant, familial or sporadic forms. Of the connective tissue diseases, it has been reported in very few cases in patients with systemic lupus erythematosus, many incorrectly labeled as Fahr syndrome without even having hypoparathyroidism. Here we describe a 30-year-old female patient with neuropsychiatric systemic lupus erythematosus manifested at diagnosis with mood disorders and anxiety, and 1-year later develops Lupus headache; Incidentally, an aneurism of the right middle cerebral artery and bilateral and symmetric calcifications of the caudate and lenticular nuclei were noted; this finding is a rarely reported manifestation of neuropsychiatric systemic lupus erythematosus...
June 2022: Radiology Case Reports
https://read.qxmd.com/read/35074702/cerebello-limbic-functional-connectivity-patterns-in-youth-at-clinical-high-risk-for-psychosis
#18
JOURNAL ARTICLE
Nikita Nogovitsyn, Paul D Metzak, Raphael F Casseb, Roberto Souza, Jacqueline K Harris, Lionel M Prati, Mojdeh Zamyadi, Signe L Bray, Catherine Lebel, Stefanie Hassel, Stephen Strother, Benjamin I Goldstein, JianLi Wang, Sidney H Kennedy, Glenda M MacQueen, Jean Addington
Youth at clinical high risk (CHR) for psychosis can present not only with characteristic attenuated psychotic symptoms but also may have other comorbid conditions, including anxiety and depression. These undifferentiated mood symptoms can overlap with the clinical presentation of youth with Distress syndromes. Increased resting-state functional connectivity within cerebello-thalamo-cortical (CTC) pathways has been proposed as a trait-specific biomarker for CHR. However, it is unclear whether this functional neural signature remains specific when compared to a different risk group: youth with Distress syndromes...
February 2022: Schizophrenia Research
https://read.qxmd.com/read/35013105/immunological-causes-of-obsessive-compulsive-disorder-is-it-time-for-the-concept-of-an-autoimmune-ocd-subtype
#19
REVIEW
Dominique Endres, Thomas A Pollak, Karl Bechter, Dominik Denzel, Karoline Pitsch, Kathrin Nickel, Kimon Runge, Benjamin Pankratz, David Klatzmann, Ryad Tamouza, Luc Mallet, Marion Leboyer, Harald Prüss, Ulrich Voderholzer, Janet L Cunningham, Katharina Domschke, Ludger Tebartz van Elst, Miriam A Schiele
Obsessive-compulsive disorder (OCD) is a highly disabling mental illness that can be divided into frequent primary and rarer organic secondary forms. Its association with secondary autoimmune triggers was introduced through the discovery of Pediatric Autoimmune Neuropsychiatric Disorder Associated with Streptococcal infection (PANDAS) and Pediatric Acute onset Neuropsychiatric Syndrome (PANS). Autoimmune encephalitis and systemic autoimmune diseases or other autoimmune brain diseases, such as multiple sclerosis, have also been reported to sometimes present with obsessive-compulsive symptoms (OCS)...
January 10, 2022: Translational Psychiatry
https://read.qxmd.com/read/34584230/glutamatergic-and-gabaergic-metabolite-levels-in-schizophrenia-spectrum-disorders-a-meta-analysis-of-1-h-magnetic-resonance-spectroscopy-studies
#20
REVIEW
Tomomi Nakahara, Sakiko Tsugawa, Yoshihiro Noda, Fumihiko Ueno, Shiori Honda, Megumi Kinjo, Hikari Segawa, Nobuaki Hondo, Yukino Mori, Honoka Watanabe, Kazuho Nakahara, Kazunari Yoshida, Masataka Wada, Ryosuke Tarumi, Yusuke Iwata, Eric Plitman, Sho Moriguchi, Camilo de la Fuente-Sandoval, Hiroyuki Uchida, Masaru Mimura, Ariel Graff-Guerrero, Shinichiro Nakajima
BACKGROUND: The glutamate (Glu) and gamma aminobutyric acid (GABA) hypotheses of schizophrenia were proposed in the 1980s. However, current findings on those metabolite levels in schizophrenia have been inconsistent, and the relationship between their abnormalities and the pathophysiology of schizophrenia remains unclear. To summarize the nature of the alterations of glutamatergic and GABAergic systems in schizophrenia, we conducted meta-analyses of proton magnetic resonance spectroscopy (1 H-MRS) studies examining these metabolite levels...
September 28, 2021: Molecular Psychiatry
keyword
keyword
78687
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.